Results

Total Results: 964 records

Showing results for "case".
Users also searched for: alcohol

341. Archived: Final Modeling Report: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-report/breast-cancer-screening-2009
     November 15, 2009 - Summary of Base-Case Input Data Sources* Appendix Table … Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. … Base-Case Analysis We compared model results for the 20 strategies to select the most efficient approach … Third, because adjuvant therapy is unlikely to reach 100% of women as modeled in our base-case analysis … U.S. mortality from 1975 to 2000: comparison of mortality results from the CISNET breast cancer base case

342. Archived: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening-september-2014
     September 22, 2014 - In 2008, estimated direct lifetime costs (in 2010 U.S. dollars) per case of chlamydial infection were

343. Uhtgkzvs Bpnj4 G4Fxuay (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/uhtgkZVs_bpNJ4_G4fXUay
     March 01, 2014 - Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force* Description: Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lung cancer. Methods: The USPSTF review…

344. Recommendation: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening
     May 08, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Recommendation Statement Prostate Cancer: Screening May 08, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be c…

345. Archived: Evidence Summary: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chronic-obstructive-pulmonary-disease-screening-2016
     April 05, 2016 - against screening for COPD in asymptomatic patients; however, many professional organizations recommend case-finding … included symptoms as part of their scoring, and the rationale for screening has largely been a case-finding … Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study.

346. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zYdjLaTCTBVUwgJTnzpVXr
     May 08, 2018 - Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force IMPORTANCE In the United States, the lifetime risk of being diagnosed with prostate cancer is approxi…

347. Archived: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
     June 11, 2019 - who inject drugs, there were 7 cases of grade 2 or greater creatinine level elevation, and all but 1 case … infection while taking PrEP had emtricitabine resistance mutations. 40 , 43 , 44 , 46 , 48-50 There was 1 case … resistance mutations (1/2 tenofovir resistance mutations, 8/13 emtricitabine resistance mutations, and 1 case … A case-control study of HIV seroconversion in health care workers after percutaneous exposure.

348. Archived: Modeling Report: Radiation-Induced Breast Cancer and Breast Cancer Death From Mammography Screening (Abstract): Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/modeling-report-radiation-induced-breast-cancer-and-breast-c/breast-cancer-screening-january-2016
     April 20, 2015 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Modeling Report: Radiation-Induced Breast Cancer and Breast Cancer Death From Mammography Screening (Abstract) Breast Cancer: Screening April 20, 2015 Recommenda…

349. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening Children for Lipid Disorders (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/lipid-disorders-screening-children-adolescents-final-rec-bulletin.pdf
     July 18, 2023 - In this case, we don’t have enough evidence to tell us whether or not screening all children and adolescents

350. Procedure Manual Section 6. Methods for Arriving at a Recommendation | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-6-methods-arriving-recommendation
     July 06, 2017 - or a large number of individual studies and lack of heterogeneity in pooled results strengthens the case … large number of, individual studies using the same intermediate and health outcomes strengthens the case … The Task Force extrapolates from existing evidence only when the case for doing so is strong. … In this case, there is a better (although not precise) estimate of the magnitude of benefit, harm, and … In this case, the body of evidence is categorized as having high certainty.

351. Archived: Final Evidence Review: Hepatitis B Virus Infection: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review46/hepatitis-b-virus-infection-screening-2004
     February 15, 2004 - Hepatitis B infection in Minnesota: a case for universal immunization.

352. Privacy Policy | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/privacy-policy
     November 01, 2015 - Some cookies collect personal information to recognize your computer in the future; this is not the case

353. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Nvjr8BPsZhy4XGc7-rGjAH
     June 18, 2018 - of CIN 2 and CIN 3, this method results in more diagnostic colpos- copies for each case detected.2-5 … In either case, screen- ing strategies may need to be adjusted. … therefore, screen- ing strategies that minimize the number of tests and colposcopies per each cancer case … Both hrHPV testing alone and cotesting would avert approximately 1 additional cancer case per 1000 women

354. Archived: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
     May 15, 2009 - containing folic acid against neural tube defects, with an odds ratio (OR) of 0.67 (95% CI, 0.58 to 0.77) in case-control … In 1995, Shaw and coworkers 9 did a case-control study and reported an OR of 0.65 (CI, 0.45 to 0.94) … A meta-analysis reported an OR of 0.67 in case-control studies and 0.52 in RCTs and cohort studies for

355. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
     June 11, 2019 - who inject drugs, there were 7 cases of grade 2 or greater creatinine level elevation, and all but 1 case … HIV infection while taking PrEP had emtricitabine resistance mutations.40,43,44,46,48-50 There was 1 case … resistance mutations (1/2 tenofovir resistance mutations, 8/13 emtricitabine resistance mutations, and 1 case … A case-control study of HIV seroconversion in health care workers after percutaneous exposure.

356. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
     April 01, 2016 - - tients without safety concerns, aspirin is recommended for those with a clear CVD benefit or on a case-by-case … Upper gastrointestinal bleeding associated with NSAIDs, other drugs and interactions: a nested case-control … gastrointestinal bleeding in primary versus secondary car- diovascular prevention: a population-based, nested case-control

357. Pzrh6M8Vucdvmsabwkaqa2 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Pzrh6m8vUcdvmsaBwKaQA2
     February 01, 2014 - they were designed to address screening issues in women without cancer (for example, retrospective or case–control … screening; P � 0.001 [68]; 15% vs. 11% in another study [69]) and more false-negative results (12 vs. 1 case … Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case … cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control

358. Recommendation: Chlamydia and Gonorrhea: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/chlamydia-and-gonorrhea-screening
     September 14, 2021 - Asymptomatic sexually transmitted diseases: the case for screening. … population-based screening guidelines versus clinical prediction rules for chlamydia and gonorrhea case

359. Screening for Ovarian Cancer: A Brief Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k2QHcwuK4NkvxFXhvGrbwY
     May 01, 2004 - Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies

360. Recommendation: Breast Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening
     April 30, 2024 - Mangione, MD, MSPH (University of California, Los Angeles); Goutham Rao, MD (Case Western Reserve University